XTL BIOPHARMACEUTICALS LTD - XTLB
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Noked Israel Ltd | History | Reduced | 49,722 | 120 | 0.02% | 0.02% | 1 | -149,166 | -75.0% | Q1 2026 | May 14, 2026 |
| SmartHarvest Portfolios, LLC | History | New | 13,351 | 32 | 0.01% | — | 2 | +13,351 | New | Q1 2026 | Apr 20, 2026 |
| RHUMBLINE ADVISERS | History | Reduced | 5,987 | 14 | 0.0% | 0.0% | 3 | -24,121 | -80.11% | Q1 2026 | May 12, 2026 |
| GAMMA Investing LLC | History | Reduced | 3,388 | 8 | 0.0% | 0.0% | 4 | -9,499 | -73.71% | Q1 2026 | Apr 06, 2026 |
| CITADEL ADVISORS LLC | History | Closed out | 0 | 0 | — | 0.0% | — | -75,866 | -100.0% | Q1 2026 | May 15, 2026 |
| XTX Topco Ltd | History | Closed out | 0 | 0 | — | 0.0% | — | -10,238 | -100.0% | Q1 2026 | May 15, 2026 |
| MORGAN STANLEY | History | Reduced | 10 | 0 | — | 0.0% | — | -1,730 | -99.43% | Q1 2026 | May 15, 2026 |
| Tower Research Capital LLC (TRC) | History | New | 244 | 0 | — | — | — | +244 | New | Q1 2026 | May 15, 2026 |